Latest The City of London Migraine Clinic Stories
Dr. Kenneth Reed will discuss a migraine treatment known as the StimPath procedure at a free migraine seminar on Sept.
Migraine treatment known as the StimPath procedure was featured on Top Docs as a treatment to help individuals who suffer from debilitating headache pain. Dallas, TX (PRWEB) August 13, 2011 Ascendant Neuro announced that the StimPath procedure, an innovative migraine treatment for people who suffer from debilitating headache pain, was featured on the July 31 edition of Top Docs of DFW, the popular Sunday morning program on KDAF-TV, Channel 33.
CHICAGO, June 7, 2011 /PRNewswire/ -- The National Headache Foundation (NHF) announced today that it is partnering with CBS Los Angeles reporter Serene Branson to launch "More Than Just a Headache," a new education campaign to raise awareness of the prevalence and impact of migraines.
Migraine specialists attending the American Headache Society (AHS) science meeting here this weekend say they believe that more government money for migraine research holds the most promise for winning the battle against the disease.
SAN DIEGO, June 6, 2011 /PRNewswire/ -- Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year(1).
CHICAGO and RESEARCH TRIANGLE PARK, N.C., April 21, 2011 /PRNewswire/ -- Could migraine patients be doing more to get the most out of their medical visits? According to a new national survey released by the National Headache Foundation (NHF) and GlaxoSmithKline, the answer is yes.
MOUNTAIN VIEW, Calif., April 7, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc.
PHILADELPHIA, March 1, 2011 /PRNewswire/ -- Health Union, LLC announced today the launch of its first website, Migraine.com (http://migraine.com).
Five years later, nearly 90 percent of patients have at least partial relief of migraine headaches.
MOUNTAIN VIEW, Calif., Dec. 21, 2010 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced completion of the LEVADEX(TM) open-label safety trial.
- Large; stout; burly.